{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:12:05Z","timestamp":1790223125112,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.contraception.2011.12.009","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T08:53:12Z","timestamp":1327913592000},"page":"110-118","source":"Crossref","is-referenced-by-count":43,"title":["Bleeding profile of a flexible extended regimen of ethinylestradiol\/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study"],"prefix":"10.1016","volume":"86","author":[{"given":"Jeffrey T.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona Grossova","family":"Garie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Trummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Elliesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.12.009_bb0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2008.02.019","article-title":"Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24\/4 regimen","volume":"78","author":"Klipping","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.12.009_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.contraception.2003.09.004","article-title":"Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives","volume":"69","author":"Wiegratz","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.contraception.2004.06.008","article-title":"Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives","volume":"70","author":"Andrist","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0010-7824(88)90035-2","article-title":"The analysis of menstrual bleeding patterns: a review","volume":"38","author":"Belsey","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jfprhc-2011-100213","article-title":"Contraceptive efficacy and tolerability of ethinylestradiol 20 \u03bcg\/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study","volume":"38","author":"Klipping","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.12.009_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.contraception.2004.05.013","article-title":"Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone","volume":"70","author":"Bachmann","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.contraception.2009.01.016","article-title":"Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24\/4-day regimen","volume":"80","author":"Hernadi","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2009.03.013","article-title":"Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24\/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21\/7 combined oral contraceptive","volume":"80","author":"Anttila","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 mcg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0060","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejogrb.2010.12.037","article-title":"Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 mug\/drospirenone 3 mg administered in a 24\/4 regimen: a pooled analysis of four open-label studies","volume":"155","author":"Anttila","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.12.009_bb0065","first-page":"63S","article-title":"Differences between the United States and Europe in clinical trials of hormonal contraceptive efficacy","volume":"111","author":"Grubb","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.12.009_bb0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5694\/j.1326-5377.1988.tb120701.x","article-title":"Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill","volume":"149","author":"Rutter","year":"1988","journal-title":"Med J Aust"},{"key":"10.1016\/j.contraception.2011.12.009_bb0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jfprhc-2011-100214","article-title":"Long-term tolerability of ethinylestradiol 20 \u03bcg\/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study","volume":"38","author":"Klipping","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.12.009_bb0080","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2139","article-title":"Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case\u2013control study using United States claims data","volume":"342","author":"Jick","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.12.009_bb0085","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.b2890","article-title":"Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case\u2013control study based on UK General Practice Research Database","volume":"342","author":"Parkin","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.12.009_bb0090","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2921","article-title":"Hormonal contraception and risk of venous thromboembolism: national follow-up study","volume":"339","author":"Lidegaard","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.12.009_bb0095","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1016\/j.fertnstert.2010.07.012","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2011.12.009_bb0100","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The risk of venous thromboembolism in users of drospirenone-containing oral contraceptive with a 24-day regimen \u2014 results from the INAS-OC study","volume":"94","author":"Dinger","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.12.009_bb0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.12.009_bb0110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","article-title":"Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives","volume":"110","author":"Seeger","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411007414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411007414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T10:55:28Z","timestamp":1593600928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411007414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0010782411007414"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.12.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}